Effect of combination of 1,25-(OH)_2-D_3 and dexamethasone on asthma in rats
Ya Ma
Abstract
Ya Ma
Abstract
AIM: To investigate the therapeutic effect of 1,25-(OH)2-D3 combined with dexamethasone on asthma in rats and its mechanism.METHODS: Forty Wister rats were randomly divided into 4 groups: nomal control group(A),asthma model group(B),group intervened by dexamethasone(C),group intervened by a combination of 1,25-(OH)2-D3 and dexamethasone(D).Group B,C and D were asthma models induced by transperitoneal injection and inhalation of ovalbumin(OVA).Peripheral blood was collected.Both total counts and the percentage of different cell types were calculated.The concentrations of IgE,IL-4 and IL-5 were determined by ELISA.RESULTS: ①After the stimulation of OVA,concentrations of IgE,IL-4 and IL-5 in peripheral blood differed statistically in each group.The concentrations of IgE,IL-4 and IL-5 were(362.84±6.26)×103 IU/L,(22.66±1.59) ng/L,(55.31±2.81) ng/L in B group,and(36.16±2.61)×103 IU/L,(8.37±0.66) ng/L,(13.45±1.07) ng/L in group A,they were statistically different in this two groups(P0.05).They were(188.25±5.55)×103 IU/L,(6.23±0.90) ng/L,(29.64±1.90) ng/L in group C,and statistically different from those in group B(P0.05).Compared with gronp B,the concentrations of IgE,IL-4 and IL-5 were greatly decreased to(182.75±6.00)×103 IU/L,(15.85±1.25) ng/L,(27.85±1.26) ng/L in group D(P0.05)②Compared with gronp A,both total counts and the percentage of EOS were increased in BALF in group B,but compared with group B,the total counts and percentage were decreased in group C and group D(P0.05).CONCLUSION: The combination of dexamethasone and 1,25-(OH)2-D3 may be more effective on the prevention of inflammation in tunica mucosa bronchiorum.The mechanism by which 1,25-(OH)2-D3 acts synergistically with dexamethasone may be that they can reduce the blood levels of IgE,IL-4 and IL-5.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To investigate the therapeutic effect of 1,25-(OH)2-D3 combined with dexamethasone on asthma in rats and its mechanism.METHODS: Forty Wister rats were randomly divided into 4 groups: nomal control group(A),asthma model group(B),group intervened by dexamethasone(C),group intervened by a combination of 1,25-(OH)2-D3 and dexamethasone(D).Group B,C and D were asthma models induced by transperitoneal injection and inhalation of ovalbumin(OVA).Peripheral blood was collected.Both total counts and the percentage of different cell types were calculated.The concentrations of IgE,IL-4 and IL-5 were determined by ELISA.RESULTS: ①After the stimulation of OVA,concentrations of IgE,IL-4 and IL-5 in peripheral blood differed statistically in each group.The concentrations of IgE,IL-4 and IL-5 were(362.84±6.26)×103 IU/L,(22.66±1.59) ng/L,(55.31±2.81) ng/L in B group,and(36.16±2.61)×103 IU/L,(8.37±0.66) ng/L,(13.45±1.07) ng/L in group A,they were statistically different in this two groups(P0.05).They were(188.25±5.55)×103 IU/L,(6.23±0.90) ng/L,(29.64±1.90) ng/L in group C,and statistically different from those in group B(P0.05).Compared with gronp B,the concentrations of IgE,IL-4 and IL-5 were greatly decreased to(182.75±6.00)×103 IU/L,(15.85±1.25) ng/L,(27.85±1.26) ng/L in group D(P0.05)②Compared with gronp A,both total counts and the percentage of EOS were increased in BALF in group B,but compared with group B,the total counts and percentage were decreased in group C and group D(P0.05).CONCLUSION: The combination of dexamethasone and 1,25-(OH)2-D3 may be more effective on the prevention of inflammation in tunica mucosa bronchiorum.The mechanism by which 1,25-(OH)2-D3 acts synergistically with dexamethasone may be that they can reduce the blood levels of IgE,IL-4 and IL-5.
Key concepts: Dexamethasone, Ovalbumin, Asthma, Immunoglobulin E, Medicine, Group B, Group A, Internal medicine